Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Post by 2021Gambleon Jan 05, 2024 2:21am
230 Views
Post# 35811909

Good things take time

Good things take time
I'm still very intrigued by the story here.  VM has shown that it moves well on good news, even if good news has been awhile in the past - that bodes well for traders and momentum players as well.

On the true long side, the story is compelling for what the business model is trying to accomplish - sure there are variables here and there that seem a little misplaced historically speaking, but hindsight is always a better view, and nobody gets everything right the first time round.

As for the current price - there are obviously some 'investors' trading it up, down and sideways - biding the time until it sails again - that's just an opportunity to accumulate imo, but when the good news does come again, they'll be chasing the tail for a few moments....

Anyway, the product is solid - everything medical takes more time than most assume, but patience and perseverance do usually/sometimes/maybe reward the patient investor ...lol - couldn't resist...

Cheers all
<< Previous
Bullboard Posts
Next >>